Lifecore Biomedical
LFCR
$6.57
Share price
-1.20%
Change (1 day)
49.32%
Change (1 year)
Categories
Operating Margin for Lifecore Biomedical (LFCR)
Operating Margin as of May 2024 (TTM): -37.31%
According to Lifecore Biomedical's latest financial reports and stock price the company's current Operating Margin is -37.31%. At the end of 2022 the company had an Operating Margin of -27.95%.
Operating Margin history for Lifecore Biomedical from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -27.95% | 275.82% |
| 2021 | -7.44% | -14.43% |
| 2020 | -8.69% | -1431.2% |
| 2019 | 0.65% | -79.13% |
| 2018 | 3.13% | 10.91% |
| 2017 | 2.82% | -180.95% |
| 2016 | -3.48% | -187.5% |
| 2015 | 3.98% | -36.56% |
| 2014 | 6.28% | -14.08% |
| 2013 | 7.30% | 14.35% |
| 2012 | 6.39% | 109.39% |
| 2011 | 3.05% | -16.74% |
| 2010 | 3.66% | -35.21% |
| 2009 | 5.65% | -20.17% |
| 2008 | 7.08% | -52.88% |
| 2007 | 15.03% | 286.46% |
| 2006 | 3.89% | 32.68% |
| 2005 | 2.93% | 38.89% |
| 2004 | 2.11% | |
| 2002 | 0.11% | -104.33% |
| 2001 | -2.53% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.